The Changing Landscape of Interstitial Lung Disease by Medical Communications Media (MCM) Education
WebcastFaculty
OVERVIEW
The Changing Landscape of Interstitial Lung Disease is organized by Medical Communications Media (MCM) Education and will be held during Feb 16, 2018 - Feb 16, 2019.
The target audience for this medical event is Pulmonologists, internal medicine specialists, primary care clinicians, radiologists, and other clinicians who encounter ILD. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description :
Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best practices in the diagnosis and treatment of ILD. This activity will examine the signs and symptoms of ILD, strategies for timely diagnosis and accurate classification, and pharmacologic and nonpharmacologic treatment options.
Conference Objectives are :
• Review the diagnosis and classification of ILD disorders.
• Discuss advances in ILD diagnosis and assessment.
• Outline treatment strategies for ILD.
• Recognize the importance of treating comorbidities.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Pulmonologists, internal medicine specialists, primary care clinicians, radiologists, and other clinicians who encounter ILD. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description :
Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best practices in the diagnosis and treatment of ILD. This activity will examine the signs and symptoms of ILD, strategies for timely diagnosis and accurate classification, and pharmacologic and nonpharmacologic treatment options.
Conference Objectives are :
• Review the diagnosis and classification of ILD disorders.
• Discuss advances in ILD diagnosis and assessment.
• Outline treatment strategies for ILD.
• Recognize the importance of treating comorbidities.
Additional details will be posted as soon as they are available.
SPECIALITIES
Pulmonary Medicine
Quick Links